My contribution to a board
I could help a board examine the meaning of a consequential measure before it becomes the basis for action. My experience includes units that changed between collection and reporting, customer allocations without sufficient evidence and comparisons whose denominators did not align. Those are practical governance questions because they can affect money, operating priorities and the way managers are judged. I would ask what the record establishes, which assumptions remain and who has authority to accept the conclusion. My existing non-executive work has also taught me that the director's contribution is different from leading the analysis personally. The board needs an understandable account and an appropriate assurance process; it should not become the data team. I would combine these questions with the financial, legal and technical expertise of other directors and learn the prospective company's own service obligations before proposing a familiar approach. The objective is a sound collective decision, not a more elaborate report for its own sake.
Judgement in practice
01A billing deadline did not make a likely allocation sufficient
Twenty-seven of 320 reviewed processing bags lacked dependable customer identifiers. I supported finance's decision to hold those allocations for review instead of using the most likely customer to complete the period's report. The known cases were resolved with evidence accepted by finance. In a board role I would ask how management recognises uncertainty before it enters a financial relationship and whether the responsible owner can delay a proposed use when the evidence is insufficient. I would not choose individual allocations from the board table. I would examine whether the process makes the gap visible, funds its resolution and retains an understandable account of the decision. A populated field should not be accepted as proof that the organisation had authority to make the claim represented by it.
02The ranking waited for a comparable basis
Four of eleven contract sites used inconsistent occupied-bed-day definitions in a proposed linen-consumption comparison. I postponed the ranking while a ₹24 lakh programme established an agreed basis. That decision improved comparability without claiming a reduction in consumption. As a director I would ask whether a performance measure distinguishes an observed difference from an explained cause. Managers should not be pushed to act on a ranking whose central assumptions remain unresolved. Once a consistent basis exists, further operating differences may still need examination. My contribution would be to help the board understand what conclusion the analysis supports and what additional evidence is needed, while resisting the temptation to treat a precise ratio as an instruction that requires no further judgement.
My first year on a board
For another board appointment I would begin by learning which measures drive the company's most consequential decisions. Through the chair's induction arrangements I would meet finance, operating and technical owners and examine the definitions behind a small number of significant reports. I would read recent board papers and assurance findings, including a case in which management changed its interpretation after further evidence. I would also understand the committee remit and the time required before agreeing where to contribute. My existing board role would help me recognise the need to ask through governance channels rather than direct analysts or operating colleagues myself. During the year I would seek feedback on whether my questions clarify decisions or draw discussion into unnecessary detail. I would want to understand how definitions change, how exceptions reach directors and where another professional judgement is required. The purpose would be to improve oversight of the evidence the board relies on, not to reproduce my current company's reporting model.
Conflicts and their management
Relzavi's customers, processing partners, suppliers and investors must be considered alongside Nerzhel's industrial apparel-repair relationships and my personal interests. The two current organisations have no trading or ownership relationship in this fictional account, but that position requires continuing review. A prospective company could create overlap with either role through a customer, supplier or owner. I would obtain the relevant consents and advice before receiving confidential material, and I would not transfer operating records or commercial knowledge between appointments. If a recurring conflict prevented participation in central decisions, I would reconsider the practicality of the seat rather than rely on routine withdrawal. Time can also create a conflict: the existing twelve-day board allocation and proposed eighteen-day allowance must be reviewed against real calendars and exceptional demands. The chair should understand those commitments before an appointment, including the possibility that a significant issue at one company could require additional attention.
My independence statement
My existing private-company seat is non-executive, not a claim of statutory independence for every appointment. A new company must assess my employment, other board duties, interests and relevant relationships under applicable Companies Act conditions, SEBI LODR requirements where relevant, committee responsibilities and directorship limits. The 2022 databank assessment result is preparation evidence, not a substitute for that company-specific assessment.
Board and committee exposure
Presented to the Board or a committee
Relzavi Clinical Linen Services
Full board by invitation on data investment and consequential operating measures
January 2021 – Present
I present data proposals and significant definition or allocation findings as CDO. I am not a director of Relzavi and do not vote on its board decisions; financial and quality owners retain their respective approvals.
Served as a director
Nerzhel Workwear Repair
Full board; no standing committee appointment
May 2023 – Present
Non-executive director of a fictional industrial apparel-repair company with thirty-six employees and FY 2026 revenue of ₹11 crore. An employee trust owns 70% and working founders 30%. I contribute to collective decisions on budgets, operating records and service capacity, without executive delivery responsibility or shareholding. Twelve days annually are allocated to this seat. It has no current trading, ownership or clinical-linen relationship with Relzavi; relationships are reviewed rather than assumed permanently absent.